Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Strasser

Showing results (301-310 of 320) with videos related to

Pageof 32
Sort By:
Nature Communications|August 25, 2022
Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistanceYexuan Deng, Sarah T Diepstraten, Margaret A Potts, et al.
Nature Communications|August 12, 2022
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistanceYexuan Deng, Sarah T Diepstraten, Margaret A Potts, et al.
Cell Death and Differentiation|April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteinsJia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
Immunity|March 22, 2018
Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent MannerLorraine A O'Reilly, Tracy L Putoczki, Lisa A Mielke, et al.
Science (New York, N.Y.)|July 3, 2025
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivoKerstin Brinkmann, Kate McArthur, Shezlie Malelang, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Immunity|August 1, 2020
Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular InfectionMarcel Doerflinger, Yexuan Deng, Paul Whitney, et al.
Cancer Discovery|October 25, 2023
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Matteo Burigotto, Sabrina Ghetti, et al.
Pageof 32

Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
Nature Communications|August 25, 2022
Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistanceYexuan Deng, Sarah T Diepstraten, Margaret A Potts, et al.
Nature Communications|August 12, 2022
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistanceYexuan Deng, Sarah T Diepstraten, Margaret A Potts, et al.
Cell Death and Differentiation|April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteinsJia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
Immunity|March 22, 2018
Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent MannerLorraine A O'Reilly, Tracy L Putoczki, Lisa A Mielke, et al.
Science (New York, N.Y.)|July 3, 2025
Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivoKerstin Brinkmann, Kate McArthur, Shezlie Malelang, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Immunity|August 1, 2020
Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular InfectionMarcel Doerflinger, Yexuan Deng, Paul Whitney, et al.
Cancer Discovery|October 25, 2023
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Matteo Burigotto, Sabrina Ghetti, et al.
Pageof 32